PharmaBoardroom

Interview: Carl Firth, CEO, ASLAN Pharmaceuticals, Taiwan

The CEO of ASLAN Pharmaceuticals discusses the fundamental changes that need to occur in the treatment of serious illnesses, the advantages of…

Interview: Kevin Leshuk, Vice President & General Manager,…

Kevin Leshuk, Vice-President and General Manager of Celgene in Canada, offers his critique of the Canadian reimbursement and approval process as well…

Interview: Tsu-Der Lee Chairman, Taipei Medical University,…

The chairman of Taipei Medical University (TMU) discusses the key challenges TMU has faced over the years, how these challenges will continue to…

Interview: Wilber Huang, Chairman, Abnova, Taiwan

Chairman of Abnova Corporation Wilber Huang discusses the company’s core strengths, Taiwan’s bilateral relationship with China’s biotech…

Interview: Christopher Tsai, Chairman, Bionet, Taiwan

The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan…

Interview: Wen-Ta Chiu, Minister of Health and Welfare, Taiwan

Taiwan's current health minister reflects on Taiwan’s prestigious healthcare system, the problems in the first generation health insurance system…

Interview: Jaw-Jou Kang, former Director General, Taiwan Food…

Jaw-Jou Kang, former Director General of Taiwan Food & Drug Administration (TFDA) discusses the key successes the company has had since 2010,…

Interview: Gail Garland CEO, Ontario Bioscience Innovation…

The CEO of OBIO discusses Ontario’s challenges and opportunities in life sciences, highlighting some of the key initiatives that the organization is…

Interview: Jim Keon, President of Canadian Generic Pharmaceutical…

Jim Keon, Preisdent of CGPA, discusses the cost-saving benefits that generic drugs have offered Canada, and offers his insights into Canada’s…

Interview: Warren Shapiro, Manager of Life Sciences North…

Warren Shapiro, manager of the North American division of Brunel’s life science sector, offers his insights into Canada’s immense human resources…

Anders Blanck – Director General, Lif Sweden

Anders Blanck of Lif Sweden discusses the Swedish healthcare system, why it’s contributing to the plunging profit margins in the pharma market, and…

Mario Piccinin and Lara Iob, Life Science Partners, Ernst &…

Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to…

Tagged with